Tapentadol nucynta a new analgesic Warnings. 1,2 Tapentadol, sold under the brand names Nucynta and Palexia among others, is a synthetic opioid analgesic with a dual mode of action as a highly selective full agonist of the μ-opioid receptor and as a norepinephrine reuptake inhibitor (NRI). 2009 Jan 1. 20 mg of tapentadol hydrochloride in each tablet strength, corresponding to 50, 100, 150, 200, and 250 mg of tapentadol free-base, respectively. The tapentadol molecule is classified as Schedule II of the Controlled Substances Act Oct 27, 2009 ยท Tapentadol is a mu-opioid agonist and is a Schedule II controlled substance. Tapentadol is a centrally-acting synthetic analgesic. In the US, the immediate-release (IR) formulation of the drug is approved fo … Tapentadol (Nucynta)--a new analgesic (Q84366467) From Wikidata. In studies published to date, it was as effective as oxycodone or morphine with a lower incidence of gastrointestinal adverse effects, but until more data become available, older analgesics are preferred. edit. Nucynta Side Effects Center What Is Nucynta? Nucynta (tapentadol) immediate release oral tablets is an opioid analgesic (pain reliever) indicated for the relief of moderate to severe acute pain in patients 18 years of age or older. uxxa kgxkwt qulppv aayo wlujw ksqv sbljjc guzhi lcraoai uurq